Back
Brainstorm Cell Therapeutics Vs. Golar LNG Industry Stock Comparison
Sell
8
BCLI
Brainstorm Cell Therapeutics
Last Price:
2.23
Seasonality Move:
-7.58%
Buy
53
GLNG
Golar LNG
Last Price:
38.77
Seasonality Move:
0.3%
Sell
8
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?
- The current Brainstorm Cell Therapeutics [BCLI] share price is $2.34. The Score for BCLI is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
- BCLI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
53
Golar LNG (GLNG)
is a Buy
Is Golar LNG a Buy, Sell or Hold?
- The current Golar LNG [GLNG] share price is $38.76. The Score for GLNG is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- GLNG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BCLI Stock Price Chart
What is Brainstorm Cell Therapeutics's stock price today?
-
The Brainstorm Cell Therapeutics share price today is $2.34
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing slight selling pressure.
GLNG Stock Price Chart
BCLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.47 | Sell |
| Relative Strength Index (14 RSI): | 24.28 | Sell |
| Chaikin Money Flow: | -18150 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.17 - 4.27) | Sell |
| Bollinger Bands (100): | (3.91 - 6.79) | Sell |
GLNG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.6 | Buy |
| Relative Strength Index (14 RSI): | 72.29 | Buy |
| Chaikin Money Flow: | -121834 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.5 - 36.8) | Buy |
| Bollinger Bands (100): | (28.44 - 35.16) | Buy |
BCLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.15 | Sell |
| 20-day SMA: | 3.59 | Sell |
| 50-day SMA: | 4.27 | Sell |
| 200-day SMA: | 5.74 | Sell |
| 8-day EMA: | 3 | Sell |
| 20-day EMA: | 3.5 | Sell |
| 50-day EMA: | 4.22 | Sell |
| 200-day EMA: | 7.23 | Sell |
GLNG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.43 | Buy |
| 20-day SMA: | 34.66 | Buy |
| 50-day SMA: | 33.65 | Buy |
| 200-day SMA: | 27.51 | Buy |
| 8-day EMA: | 37.54 | Buy |
| 20-day EMA: | 35.65 | Buy |
| 50-day EMA: | 33.88 | Buy |
| 200-day EMA: | 29.07 | Buy |
Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.55 per share, and an increase next year of $0.08 per share.
Golar LNG Earnings Growth & GLNG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.93 per share, and an increase next year of $0.79 per share.
Brainstorm Cell Therapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Golar LNG Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||